# Filing Detail

Form DEFR14A - Revised definitive proxy soliciting materials:
SEC Accession No. 0001193125-25-107123
Filing Date
2025-04-30
Accepted
2025-04-30 16:04:48
Documents
17

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFR14A | d74158ddefr14a.htm iXBRL | DEFR14A | 461265
3 | GRAPHIC | g74158g01a03.jpg | GRAPHIC | 148248
4 | GRAPHIC | g74158g01a04.jpg | GRAPHIC | 179255
5 | GRAPHIC | g74158g17d21.jpg | GRAPHIC | 27792
6 | GRAPHIC | g74158g89a99.jpg | GRAPHIC | 38454
| Complete submission text file | 0001193125-25-107123.txt |  | 1755628

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
2 | XBRL TAXONOMY EXTENSION SCHEMA | vor-20241231.xsd | EX-101.SCH | 2487
19 | EXTRACTED XBRL INSTANCE DOCUMENT | d74158ddefr14a_htm.xml | XML | 5406

Mailing Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140
Business Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140 617-655-6580
Vor Biopharma Inc. (Filer) CIK: 0001817229 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFR14A | Act: 34 | File No.: 001-39979 | Film No.: 25894872
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)